Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-resistant tuberculosis

L W Riley1

  • 1Division of International Medicine, Cornell University Medical College, New York, New York 10021.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The rheumatic heart disease healthcare paradox: disease persistence in slums despite universal healthcare coverage-a provider perspective qualitative study.

Public health·2019
Same author

A multiplexed, indirect enzyme-linked immunoassay for the detection and differentiation of E. coli from other Enterobacteriaceae and P. aeruginosa from other glucose non-fermenters.

Journal of microbiological methods·2019
Same author

Serum antiphospholipid antibody levels as biomarkers for diagnosis of pulmonary tuberculosis patients.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2018
Same author

Diabetes increases the risk of recent-transmission tuberculosis in household contacts in São Paulo, Brazil.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2017
Same author

Directly observed therapy of tuberculosis in Brazil: associated determinants and impact on treatment outcome.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2015
Same author

Pandemic lineages of extraintestinal pathogenic Escherichia coli.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2014
Same journal

Antibiotic Treatment Duration for Uncomplicated Monomicrobial Enterococcal Bloodstream Infection: A Multicenter Target Trial Emulation.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Larger Blood Volume Increases Detection of Fastidious Mycobacteria and Fungi in Blood Culture.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Anticalcitonin: Limited utility of a context-dependent biomarker demonstrated in another real-world data set.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Procalcitonin Testing in Community-Acquired Pneumonia.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Wanted: A Relevant Correlate of Protection for Dengue Vaccines.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Safety and Immunogenicity of the Live-Attenuated Quadrivalent Dengue Vaccine V181 Compared With Butantan-DV Among Healthy Adults in Brazil: A Randomized, Double-Blind, Phase 2 Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
See all related articles

Multidrug-resistant tuberculosis (MDRTB) is a growing global health crisis, exacerbated by factors like HIV and poor healthcare. Urgent research is needed to understand resistance, improve diagnostics, and develop effective prevention and treatment strategies for MDRTB.

Area of Science:

  • Infectious Diseases
  • Epidemiology
  • Microbiology

Background:

  • Multidrug-resistant tuberculosis (MDRTB) is an escalating global health concern.
  • Factors contributing to MDRTB include the HIV/AIDS pandemic, inadequate public health infrastructure, and insufficient healthcare provider training.

Purpose of the Study:

  • To highlight the critical challenges in managing MDRTB.
  • To identify key areas requiring further epidemiological, clinical, and laboratory research.
  • To emphasize the need for quantitative risk assessments and improved diagnostic methods.

Main Methods:

  • The abstract discusses contributing factors and challenges based on existing knowledge.
  • It calls for quantitative risk estimation and further research into drug resistance mechanisms.

Related Experiment Videos

  • No specific experimental methods are detailed; it's a review and call for research.

    • Main Results:

    • MDRTB poses a significant mortality risk, exceeding 80% in HIV-infected individuals and remaining high in HIV-negative patients.
    • Current management is hindered by the lack of rapid detection methods for resistant Mycobacterium tuberculosis strains.
    • Essential data on infection risk, disease progression, and cure rates are quantitatively undetermined.

    Conclusions:

    • There is an urgent need for expanded research into MDRTB, focusing on epidemiology, clinical management, and laboratory diagnostics.
    • Understanding resistance mechanisms and developing effective chemoprophylaxis strategies are crucial.
    • Quantitative risk assessments are vital for community-level MDRTB prevention strategies.